We are live on
!
Find out more
BRM
Boston Research & Management Portfolio holdings
AUM
$421M
1-Year Est. Return
16.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$184M
AUM Growth
+$7.78M
(+4.4%)
Cap. Flow
+$55K
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
99
New
4
Increased
25
Reduced
35
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$534K |
| 2 |
CVS Health
CVS
|
+$263K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$256K |
| 4 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$225K |
| 5 |
Clorox
CLX
|
+$207K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcoa
AA
|
+$695K |
| 2 |
iShares US Healthcare ETF
IYH
|
+$396K |
| 3 |
Apple
AAPL
|
+$242K |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$201K |
| 5 |
Microsoft
MSFT
|
+$177K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.31% |
| 2 | Technology | 13.13% |
| 3 | Financials | 12.23% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Staples | 10.09% |
Similar funds
SCV
RAG
TFP
AFA
CWM
MG
HWMG
AI
Boston Research & Management's Q1 2017 Portfolio in Review
As of Q1 2017, Boston Research & Management held 99 positions worth $184M, up 4.4% from $176M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Boston Research & Management's Q1 2017 filing shows 4 new, 25 increased, 35 reduced and 3 closed positions. Its largest new stake was Mandiant, Inc. Common Stock: 18,900 shares worth $238K. The largest sale was Alcoa, an estimated $695K.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- Boston Research & Management's largest Q1 2017 buy was Mandiant, Inc. Common Stock: 18,900 shares worth $238K.
- Boston Research & Management added most to Colgate-Palmolive in Q1 2017, an estimated $534K increase.
- Boston Research & Management's biggest Q1 2017 reduction was Apple, cutting an estimated $242K.
- Boston Research & Management fully exited Alcoa in Q1 2017, selling an estimated $695K.
- Boston Research & Management's ten largest holdings make up 23% of its $184M portfolio in Q1 2017.
- Boston Research & Management opened 4 new positions and closed 3 in Q1 2017.
- Boston Research & Management's portfolio value rose 4.4% quarter-over-quarter to $184M.
Based on Boston Research & Management's 13F filing for Q1 2017, filed 5 May 2017.